Krystal Biotech Inc banner

Krystal Biotech Inc
F:4KB

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
F:4KB
Watchlist
Price: 253.1 EUR 4.76% Market Closed
Market Cap: €7.2B

Wall St Price Targets

4KB Price Targets Summary
Krystal Biotech Inc

Wall Street analysts forecast 4KB stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 4KB is 183.93 EUR with a low forecast of 124.43 EUR and a high forecast of 228.63 EUR.

Lowest Forecast
Price Target
124.43 EUR
51% Downside
Average Forecast
Price Target
183.93 EUR
27% Downside
Highest Forecast
Price Target
228.63 EUR
10% Downside
Krystal Biotech Inc Competitors:
Price Targets
SUPN
Supernus Pharmaceuticals Inc
25% Upside
FAST
Fastenal Co
7% Upside
LH6
LHC Group Inc
30% Upside

Revenue
Forecast

N/A
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 17%.

Operating Income
Forecast

N/A
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Operating Income over the next 8 years is 26%.

Net Income
Forecast

N/A
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-29%
Average Miss
N/A
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-29%
Average Miss

The compound annual growth rate for Net Income over the next 7 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 4KB's stock price target?
Price Target
183.93 EUR

According to Wall Street analysts, the average 1-year price target for 4KB is 183.93 EUR with a low forecast of 124.43 EUR and a high forecast of 228.63 EUR.

What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
17%

The compound annual growth rate for Revenue over the next 8 years is 17%.

What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
26%

The compound annual growth rate for Operating Income over the next 8 years is 26%.

What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
16%

The compound annual growth rate for Net Income over the next 7 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett